-

ATEC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Alphatec Holdings, Inc.

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP continues its investigation on behalf of Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (NASDAQ:ATEC) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.

[LEARN MORE ABOUT THE INVESTIGATION]

What Happened?

On May 5, 2026, Alphatec reported its first quarter 2026 financial results and updated its full-year outlook. Among other things, the Company disclosed total revenue of $192 million for the quarter. Alphatec also disclosed EOS revenue of $14 million for the quarter (EOS is Alphatec’s proprietary imaging and informatics platform for diagnostic and surgical planning applications in spinal surgery). During the Company’s earnings call, management stated that the Company’s first quarter revenue was below its internal expectations, primarily due to a shortfall in EOS sales performance. In addition, Alphatec reduced its full-year 2026 EOS revenue outlook to approximately $77 million, compared to prior guidance of approximately $85 million. During the earnings call, management discussed execution issues related to EOS installations. Among other things, management stated that “installation timing was a challenge in the quarter” and that the Company had “committed to a number of units” that it “did not fulfill.” Management further stated that EOS revenue recognition follows installation. On this news, the price of Alphatec shares declined by $3.24 per share, or approximately 32%, from $10.23 per share on May 5, 2026 to close at $6.99 on May 6, 2026.

What Should I Do?

At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.

If you purchased or otherwise acquired Alphatec securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

[LEARN MORE ABOUT SECURITIES CLASS ACTIONS]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:ATEC

Release Versions

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

More News From Kirby McInerney LLP

ENOVA INTERNATIONAL, INC. ENVA INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 23.4% Share Drop

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Enova International, Inc. (“Enova” or the “Company”) (NYSE: ENVA) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE FIRM’S INVESTIGATION]What Happened?On September 14, 2026, Enova disclosed that it had withdrawn its applications with the Office of t...

Securities Class Action Filed Against Endava plc – DAVA Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Endava plc (“Endava” or the “Company”) (NYSE: DAVA) securities between September 4, 2025 and September 21, 2026, inclusive (“the Class Period”). If you suffered a loss on your Endava investments, you have until November 30, 2026 to request lead plaintiff appointment.[CONTACT THE FIRM IF YOU SUFFERED A LOSS]Investors are encouraged to fill out the...

Securities Class Action Filed Against Anavex Life Sciences Corp. – AVXL Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Anavex Life Sciences Corp. (“Anavex” or the “Company”) (NASDAQ: AVXL) securities between November 26, 2025 and August 28, 2026, inclusive (“the Class Period”). If you suffered a loss on your Anavex investments, you have until November 30, 2026 to request lead plaintiff appointment.[CONTACT THE FIRM IF YOU SUFFERED A LOSS]Investors are encouraged...
Back to Newsroom